Moderna Inc MRNA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:59 PM EST
374.82quote price arrow up+6.31 (+1.71%)
Volume
1,530,479
Close
368.51quote price arrow up+38.88 (+11.80%)
Volume
30,374,767
52 week range
102.66 - 497.49
Loading...
  • Open370.33
  • Day High376.65
  • Day Low350.27
  • Prev Close329.63
  • 52 Week High497.49
  • 52 Week High Date08/10/21
  • 52 Week Low102.66
  • 52 Week Low Date12/31/20

Key Stats

  • Market Cap148.749B
  • Shares Out403.65M
  • 10 Day Average Volume11.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.34
  • YTD % Change252.74

KEY STATS

  • Open370.33
  • Day High376.65
  • Day Low350.27
  • Prev Close329.63
  • 52 Week High497.49
  • 52 Week High Date08/10/21
  • 52 Week Low102.66
  • 52 Week Low Date12/31/20
  • Market Cap148.749B
  • Shares Out403.65M
  • 10 Day Average Volume11.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.34
  • YTD % Change252.74

RATIOS/PROFITABILITY

  • EPS (TTM)16.28
  • P/E (TTM)22.63
  • Fwd P/E (NTM)8.38
  • EBITDA (TTM)3.918B
  • ROE (TTM)72.43%
  • Revenue (TTM)7.02B
  • Gross Margin (TTM)84.20%
  • Net Margin (TTM)49.79%
  • Debt To Equity (MRQ)7.26%

EVENTS

  • Earnings Date02/23/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO5:4205:42
Covid could become like the flu, creating opportunities in science, says Cantor's Alethia Young

Profile

MORE
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases...
Noubar Afeyan
Non-Executive Chairman
Stephane Bancel
Chief Executive Officer
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technology Officer
Lori Henderson J.D.
General Counsel
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
BNTX
BioNTech SE
362.52+14.52+4.17%
REGN
Regeneron Pharmaceuticals Inc
654.40+11.05+1.72%
BIIB
Biogen Inc
236.11-6.79-2.80%
ILMN
Illumina Inc
370.81+1.02+0.28%
SYNH
Syneos Health Inc
99.99+1.19+1.20%